Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · July 14, 2023

GLP-1 Receptor Agonists and the Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes

The Journal of Clinical Endocrinology and Metabolism

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Journal of Clinical Endocrinology and Metabolism
GLP-1 Receptor Agonists and Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
J. Clin. Endocrinol. Metab. 2023 Jun 16;108(7)1806-1812, M Banerjee, R Pal, S Mukhopadhyay, K Nair

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading